E-LIB Suche - Ergebnisse für: Krieckaert, Charlotte LM

1

EULAR study group on 'MHC-I-opathy': identifying disease-ov..:

Kuiper, Jonas JW ; Prinz, Jörg C ; Stratikos, Efstratios...
Annals of the Rheumatic Diseases. 82 (2023) 7 - p. 887-896 , 2023

Link: https://doi.org/10.1136/..

2

Are we ready for therapeutic drug monitoring of biologic th..:

Krieckaert, Charlotte LM ; Lems, Willem F
Arthritis Research & Therapy. 13 (2011) 4 - p. 120 , 2011

Link: https://doi.org/10.1186/..

3

EULAR study group on 'MHC-I-opathy': identifying disease-ov..:

Kuiper, Jonas JW ; Prinz, Jörg C ; Stratikos, Efstratios...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313995/. , 2023

Link: http://www.ncbi.nlm.nih...

4

EULAR study group on 'MHC-I-opathy': identifying disease-ov..:

Kuiper, Jonas Jw ; Prinz, Jörg C ; Stratikos, Efstratios...
https://boris.unibe.ch/181065/. , 2023

Link: https://boris.unibe.ch/1..

5

EULAR study group on 'MHC-I-opathy' : identifying disease-o..:

Kuiper, Jonas Jw ; Prinz, Jörg C ; Stratikos, Efstratios...
Annals of the Rheumatic Diseases. , 2023

Link: http://hdl.handle.net/10..

6

Successful reduction of overexposure in patients with rheum..:

l'Ami, Merel J ; Krieckaert, Charlotte Lm ; Nurmohamed, Michael T...
l'Ami , M J , Krieckaert , C L , Nurmohamed , M T , van Vollenhoven , R F , Rispens , T , Boers , M & Wolbink , G J 2018 , ' Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations : an open-label, non-inferiority, randomised clinical trial ' , Annals of the Rheumatic Diseases , vol. 77 , no. 4 , pp. 484-487 . https://doi.org/10.1136/annrheumdis-2017-211781. , 2018

Link: https://research.vumc.nl..

7

Are we ready for therapeutic drug monitoring of biologic th..:

Krieckaert, Charlotte LM ; Lems, Willem F
http://arthritis-research.com/content/13/4/120. , 2011

Link: http://arthritis-researc..

8

Are we ready for therapeutic drug monitoring of biologic th..:

Krieckaert, Charlotte LM ; Lems, Willem F
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239348. , 2011

Link: http://www.ncbi.nlm.nih...

9

The effect of methotrexate on tumour necrosis factor concen..:

Rispens, Theo ; Wolbink, Gerrit J ; Nurmohamed, Michael T...
Rheumatology. 59 (2019) 7 - p. 1703-1708 , 2019

Link: https://doi.org/10.1093/..

10

Biologicals and bone loss:

Krieckaert, Charlotte L.M. ; Lems, Willem F.
Therapeutic Advances in Musculoskeletal Disease. 4 (2012) 4 - p. 245-247 , 2012

Link: https://doi.org/10.1177/..

11

Therapeutic drug monitoring of biopharmaceuticals in inflam..:

Krieckaert, Charlotte ; Hernández-Breijo, Borja ; Gehin, Johanna Elin...
RMD Open. 8 (2022) 2 - p. e002216 , 2022

Link: https://doi.org/10.1136/..

12

COVID-19 vaccine acceptance over time in patients with immu..:

Boekel, Laura ; Hooijberg, Femke ; Besten, Yaëlle R...
The Lancet Rheumatology. 4 (2022) 5 - p. e310-e313 , 2022

Link: https://doi.org/10.1016/..

13

Efficacious transition from reference infliximab to biosimi..:

Layegh, Zohra ; Ruwaard, Jill ; Hebing, Renske C. F....
International Journal of Rheumatic Diseases. 22 (2019) 5 - p. 869-873 , 2019

Link: https://doi.org/10.1111/..

14

IgG4 Production Against Adalimumab During Long Term Treatme..:

van Schouwenburg, Pauline A. ; Krieckaert, Charlotte L. ; Nurmohamed, Michael...
Journal of Clinical Immunology. 32 (2012) 5 - p. 1000-1006 , 2012

Link: https://doi.org/10.1007/..

15

Comparison of long‐term clinical outcome with etanercept tr..:

Krieckaert, Charlotte L. ; Jamnitski, Anna ; Nurmohamed, Michael T....
Arthritis & Rheumatism. 64 (2012) 12 - p. 3850-3855 , 2012

Link: https://doi.org/10.1002/..